<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104099">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01778361</url>
  </required_header>
  <id_info>
    <org_study_id>HIVUPBEAT</org_study_id>
    <nct_id>NCT01778361</nct_id>
  </id_info>
  <brief_title>HIV UPBEAT: Understanding the Pathology of Bone Disease in HIV-infected Patients.</brief_title>
  <acronym>UPBEAT</acronym>
  <official_title>HIV UPBEAT: Understanding the Pathology of Bone Disease in HIV-infected. A Prospective Cohort Study of HIV-infected Patients and HIV-negative Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College Dublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health Research Board, Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College Dublin</source>
  <oversight_info>
    <authority>Ireland: Research Ethics Committee, Mater Misericordiae University Hospital, Dublin</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the prevalence of osteopenia and osteoporosis in the HIV positive population,
      relatively little is known about the underlying pathology. This prospective cohort study
      aims to gain further understanding about a number of issues relating to low bone mineral
      density in HIV-infected subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will follow HIV positive and negative subjects annually for 3 years. The aims of
      this study include:

        -  to describe the pathology underlying low bone mineral density

        -  to assess the relationship between low bone mineral density and antiretroviral therapy
           exposure

        -  to assess the relationship between low bone mineral density and vitamin D /PTH status
           and/or markers of bone metabolism

        -  to assess the relationship between osteopenia and subsequent changes in bone mineral
           density and markers of bone metabolism

        -  to assess the validity of the currently available fracture risk assessment tool in
           predicting fractures in HIV positive populations
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Bone pathology</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To describe abnormalities in bone pathology in bone biopsies from HIV-infected subjects with low bone mineral density by comparing biopsy indices to reference ranges.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of change in bone mineral density</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To determine rates of change in bone mineral density in HIV-positive patients compared to HIV-negative controls</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Fracture incidence</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the validity of currently available fracture risk assessment tools in predicting fracture risk in HIV-infected patients.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>HIV positive</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV negative</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, plasma, buffy coat, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV positive patients and HIV negative subjects
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;18 years

          -  be able to provide written, informed consent

          -  be able to attend the research centre in a fasting state and undergo DEXA   scanning

        Exclusion Criteria:

          -  Subjects on bisphosphonate therapy at screening

          -  Pregnant or breastfeeding female subjects

          -  Subjects with a previous clinical history of primary hyperthyroidism or HIV negative
             subjects with elevated parathyroid hormone at screening

          -  HIV-negative subjects with a prior history of osteoporosis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick WG Mallon, MB BCh, BSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HIV Molecular Research Group, University College Dublin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aoife G Cotter, MB BCh BAO</last_name>
    <email>aoife.cotter@ucdconnect.ie</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sibongile Simelane</last_name>
    <email>sibongile.simelane@ucd.ie</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mater Misericordiae University Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>D 7</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aoife G Cotter, MB BAO BCh</last_name>
      <email>aoife.cotter@ucdconnect.ie</email>
    </contact>
    <investigator>
      <last_name>Patrick WG Mallon, MB BCh, PhD, FRCPI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gerard Sheehan, MB BCh BAO, FRCPI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Lambert, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 25, 2013</lastchanged_date>
  <firstreceived_date>January 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College Dublin</investigator_affiliation>
    <investigator_full_name>Patrick Mallon</investigator_full_name>
    <investigator_title>Associate Dean of Post-graduate Research, School of Medicine and Medical Sciences, Head of HIV Molecular Research Group, Consultant Infectious Diseases.</investigator_title>
  </responsible_party>
  <keyword>Human immunodeficiency virus</keyword>
  <keyword>low bone mineral density</keyword>
  <keyword>osteopenia</keyword>
  <keyword>osteoporosis</keyword>
  <keyword>fracture</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bone Diseases</mesh_term>
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
